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Summary The chronic respiratory questionnaire (CRQ) has demonstrated excellent
measurement properties in patients with chronic obstructive pulmonary disease
(COPD), but in its original form it is limited by the requirement for interviewer-
administration and the individualised dyspnoea questions. The objective of this
randomised trial was to examine the evaluative properties of the interviewer and
self-administered German CRQ as well as of a standardised CRQ dyspnoea domain. In
a multinational trial we randomly allocated 71 patients with COPD to complete the
interviewer administered CRQ (CRQ-IA) or the self-administered CRQ (CRQ-SA) and
other validation measures at the beginning and end of a respiratory rehabilitation
program. We assessed and compared responsiveness and longitudinal validity of the
CRQ. The change scores of all CRQ domains were above the minimal clinically
important difference of 0.5. Responsiveness of the fatigue domain was higher for the
CRQ-SA compared to CRQ-IA (P ¼ 0:02), but there was no difference in responsive-
ness on the other domains. Compared to the standardised dyspnoea domain the
individualised dyspnoea questions tended to show greater responsiveness for both
the CRQ-IA (P ¼ 0:07) and CRQ-SA (P ¼ 0:10). We found better longitudinal validity
for the CRQ-SA represented by larger correlations between CRQ change scores and
those of other validation instruments. Taken these results into consideration,
researchers in COPD, in particular those in German-language countries can utilise
any one of four CRQ formats that have proved both valid and responsive.
& 2003 Elsevier Ltd. All rights reserved.
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Introduction
Projections suggest that COPD is the only cause of
death from chronic disease that will increase
worldwide until 2020.1 In Switzerland, Germany
and Austria the smoking prevalence is above 30%2
and the decline in smoking prevalence seen in
North-America and Great-Britain is absent.3–5 In
1998, there were about 3–5 million patients with
COPD in German-speaking countries.6
Health-related quality of life (HRQL) in patients
with COPD is important in determining response to
treatment.7,8 Although there are German transla-
tions of COPD specific quality of life instruments,
these translations have not been properly validated
in clinical trials.
Two widely used COPD-specific questionnaires
are available in English: the interviewer-adminis-
tered ‘‘Chronic Respiratory Questionnaire’’ (CRQ)9
and the self-administered ‘‘St George’s Respiratory
Questionnaire’’.10 The CRQ is a valid and reliable
instrument.11,12 Compared to the St. George’s
Respiratory Questionnaire and generic question-
naires, the CRQ is more responsive to small but
important changes of HRQL.13,14 Another advantage
of the CRQ is the simple analysis and interpret-
ability supported by a significant body of evi-
dence.15–17
Despite its established psychometric properties,
investigators have criticised the CRQ because it is
interviewer-administered and the individualised
dyspnoea domain makes comparisons between
patients with different limitations in their
daily activities difficult.11,18 Although a self-
administered19 and a standardised20 version of the
CRQ exist in English, further validation and descrip-
tion of the measurement properties associated with
self-administration and standardisation is impor-
tant before widespread use of these simplified
administration formats.
The objective of this study was to assess and
compare the measurement properties of the self-
administered and the interviewer-administered
version of the German CRQ including standardised
dyspnoea questions.
Methods
Patients
We included patients with COPD defined as FEV1/
FVCo70% predicted and postbronchodilator
FEV1o80% predicted, German as the first or daily
language, age 440 years and ability to complete
the CRQ within one session. We excluded patients
with inability to read or write, with cognitive
difficulties (due to dementia, substance abuse or
neurological disorders), with cancer or lung dis-
eases other than COPD. We recruited patients
consecutively from August to November 2002. All
patients followed a multidisciplinary program with
emphasis on physical exercise. Additional elements
were educational sessions, psychological support
and relaxation therapies.
Study design
We conducted a multinational clinical trial to
concurrently validate a German translation of the
interviewer-administered CRQ (CRQ-IA) and the
self-administered CRQ (CRQ-SA) including a stan-
dardised dyspnoea domain. In order to allow
comparisons between these administration formats
we randomised patients to complete either the
CRQ-IA or the CRQ-SA. Within each group (CRQ-IA or
CRQ-SA) patients completed both the individualised
and standardised dyspnoea questions. To eliminate
order effects we also randomised in a 2 2
factorial design the order of receiving the indivi-
dualised or standardised dyspnoea questions. We
produced a computer-generated randomisation list
with blocks of four per centre. To ensure conceal-
ment of allocation, the centre’s research leaders
who were not aware of block size called the study
coordinator (MP) to obtain group assignment for
each participant. We assessed all patients within 3
days after enrolment (baseline) and after at least
two weeks of intense respiratory rehabilitation
(follow-up) in any of the programs (total duration
of rehabilitation 2–3 weeks). We recruited
patients from four rehabilitation centres (three
inpatient and one outpatient programme) in
Switzerland (Zuercher Hoehenklinik Wald and
Klinik Barmelweid, Barmelweid), Germany
(Pulmoresearch Institute, Grosshansdorf) and
Austria (Rehabilitationszentrum, Weyer/Enns).
All interviewers completed standardised training
session on the use and administration of the CRQ
from one of the investigators. All local ethics
committees approved the study protocol and all
patients provided informed consent prior to parti-
cipation in the study.
The German version of the chronic
respiratory questionnaire
All questions of the German interviewer and self-
administered version are identical and correspond
to those of the English versions.9,20 The CRQ
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includes questions across the four domains of
fatigue, emotional function, mastery and dys-
pnoea. Questions covering the domains of fatigue,
emotions and mastery are standardised and pa-
tients answer each question on a seven-point scale
to express the degree of disability from 1 (max-
imum impairment) to 7 (no impairment). For the
individualised dyspnoea domain, respondents se-
lect activities from a list of 26 items that cause the
greatest degree of shortness of breath in daily life
or to list important activities not on the list.
Subsequently, patients select the five activities of
greatest importance to them and indicate the
breathlessness associated with these activities.
The standardised dyspnoea domain comprises five
questions concerning activities that cause shortness
of breath in most patients with COPD.20 These five
activities are: (a) taking care of your basic needs
(bathing, showering, eating or dressing), (b) walk-
ing, (c) feeling emotional such as angry or upset,
(d) performing chores (such as housework, shop-
ping, groceries), (e) participating in social activ-
ities. We used the informed version of the CRQ that
allows patients at follow-up to see their prior
responses.21
For translation and cultural adaptation of the
CRQ in the German-speaking countries, we used a
standard approach for translation, back transla-
tion, pilot testing and evaluation of instrument
test–retest reliability and internal consistency
reliability.22 We will describe these and other
details of the development process as well as the
discriminative properties of the CRQ versions in a
separate report.
Validation instruments to assess longitudinal
validity of the CRQ
We used the self-administered SF-36 Health Survey,
a generic instrument for assessment of the health-
related quality of life of patients. The SF-36 assesses
8 subscales of health-related quality of life. The SF-
36 has been translated into German and validated as
part of the IQOLA project.23 Other investigators
used the SF-36 in trials with COPD patients
participating in respiratory rehabilitation.24
The FT is an anchor-based visual analogue scale
from 0 to 100 where 0 (dead) represents the worst
and 100 (full health) the best health state.
Accumulating evidence suggests that the FT works
well as an evaluative instrument in various groups,
including patients with chronic obstructive pul-
monary disease (COPD).25
We used the six-minute walking test (6MWT) to
assess functional exercise capacity. It measures
the distance a patient can walk within 6min.
In addition, we used a modified Borg scale in
German26 to assess the intensity of perceived
dyspnoea at the end of the 6MWT. The Borg scale
consisted of a vertical line labelled 0–10 and with
verbal descriptors. Zero represented ‘‘no dyspnoea
at all’’ and 10 ‘‘maximal dyspnoea’’.
Statistical analysis
We calculated the mean score for each CRQ
domain by summing the scores for each domain
question and dividing it by the number of scored
questions. We used parametric tests because the
distributions on the seven points Likert-type scale
were normal.
We calculated the mean change between base-
line and follow-up domain scores and the corre-
sponding 95% confidence intervals. We used paired
t-tests to determine if baseline and follow-up
scores differed significantly. To compare the re-
sponsiveness of the CRQ-IA and CRQ-SA we used
independent t-tests and, finally, we used paired t-
tests to compare the individualised and standar-
dised dyspnoea domain.
To assess longitudinal construct validity, we
calculated Pearson’s correlation coefficients be-
tween change scores on the CRQ domains and the
FT, SF-36, 6MWT and Borg scale.
We were interested in comparing the number of
missing items between the different formats of
administration. Our main interest was in the
comparison of missing or not applicable items
resulting from standardisation of the dyspnoea
domain.
For calculating the required sample size, we used
the following formula for paired observations:
n ¼ ½ðZaþ ZbÞ SD/D]2.27 where n represents the
number of patients required per group, Za and Zb
the terms to set the level of significance and the
power, SD the standard deviation of the instrument
and D the desired difference between baseline
and follow-up. The minimal sample size re-
quired per group was27 to show effects for all
four dimensions of 0.5 (the minimal important
difference that patients or physicians judge as
important15) points assuming a standard deviation
of 0.8, a ¼ 0:05 and b ¼ 0:10: With an estimated
dropout rate of 20%, the required sample size
increased to 32 per group.
All statistical analyses were performed with SPSS
for Windows version 10.0 (SPSS Inc, Chicago, IL,
USA).
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Results
We recruited patients from the Zuercher Hoehenk-
linik Wald (n ¼ 20), the Klinik Barmelweid (n ¼ 20),
the Rehabilitationszentrum Weyer/Enns (n ¼ 12)
and the Pulmoresearch Institute Hamburg
(n ¼ 28). We randomly assigned them to either
the CRQ-IA group (n ¼ 40) or CRQ-SA group
(n ¼ 40). Nine patients did not complete the study
for the following reasons: five withdrew for non-
specified reasons, two did not complete the
rehabilitation program and upon review two pa-
tients did not meet the a priori inclusion criteria.
Table 1 shows that patients randomised to the CRQ-
IA or CRQ-SA had similar baseline characteristics.
In Table 2, we present the baseline and follow-up
scores of the CRQ domains by randomisation group.
Compared to the CRQ-IA, baseline scores on the
CRQ-SA were consistently lower for each of the
domains. However, only for the individualised
dyspnoea domain was the difference significant
(P ¼ 0:02). The differences between the CRQ-IA
and CRQ-SA in the follow up scores were small and
not statistically significant.
Both the interviewer and self-administered ad-
ministration demonstrated statistically and clini-
cally significant improvement over the course of
rehabilitation (Table 3). The lower limits of the
confidence intervals were above the minimum
important difference of 0.5 for all domains. The
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Table 1 Demographic information for patients randomised to the CRQ-IA or CRQ-SA.
Patient characteristic Interviewer administration (n ¼ 38) Self-administration (n ¼ 33)
Male (%) 24 (63.2) 23 (69.7)
Female (%) 14 (36.8) 10 (30.3)
Agen 67.4 (8.7) 67.7 (8.3)
FEV1 in % predicted
n 45.1 (15.6) 45.1 (15.5)
FEV1/FVC in % predicted
n 48.5 (13.3) 49.9 (10.5)
Pack yearsn 44.9 (26.1) 46.8 (27.6)
Six minute walking test at baselinen 359 (111) 361 (134)
Social status
Living alone (%) 8 (21.1) 12 (36.4)
Working (%) 6 (15.8) 5 (15.2)
Not working (%) 10 (26.3) 5 (15.2)
Retired (%) 22 (57.9) 23 (69.7)
Duration of rehabilitation (days)n 16.5 (3.0) 16.9 (3.8)
nMean (standard deviation).
Table 2 Baseline and follow-up scores of the interviewer and self-administered formats of the CRQ.
Domain CRQ-IA (n ¼ 38) CRQ-SA (n ¼ 33) D (95% confidence interval, P valuen)
Dyspnoea individualised Baseline 3.1770.66 2.7270.91 0.45 (0.08; 0.83; P ¼ 0:02)
Follow-up 4.1970.93 3.9771.37 0.22 (0.32; 0.77; P ¼ 0:41)
Dyspnoea standardised Baseline 4.0071.01 3.5571.33 0.45 (0.11; 1.01; P ¼ 0:11)
Follow-up 4.7870.95 4.5971.31 0.19 (0.34; 0.73; P ¼ 0:48)
Fatigue Baseline 4.1971.20 3.8171.13 0.38 (0.17; 0.94; P ¼ 0:17)
Follow-up 5.0270.97 5.2071.03 0.17 (0.64; 0.30; P ¼ 0:47)
Emotional function Baseline 4.3870.99 4.1271.22 0.26 (0.26; 0.79; P ¼ 0:32)
Follow-up 5.4170.84 5.2470.95 0.17 (0.25; 0.60; P ¼ 0:42)
Mastery Baseline 4.3771.24 4.2571.42 0.12 (0.50; 0.76; P ¼ 0:69)
Follow-up 5.2671.03 5.4670.89 0.21 (0.66; 0.25; P ¼ 0:38)
CRQ domain scores with values from 1 (largest impairment) to 7 (no impairment); CRQ-IA¼ Interviewer administered German
chronic respiratory questionnaire; CRQ-SA¼ self-administered German chronic respiratory questionnaire; Values are mean7
standard deviation; D¼difference between the CRQ-IA and CRQ-SA.
nP-values for independent t-tests to compare the CRQ-IA and CRQ-SA.
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distribution of the change scores was wider for the
CRQ-SA compared to the CRQ-IA. When we com-
pared the change scores of the CRQ-IA and CRQ-SA,
we found a significant difference between the
fatigue domains (P ¼ 0:02). The change scores of
the dyspnoea, emotional function and mastery
domains did not differ significantly. For both the
CRQ-IA and CRQ-SA responsiveness tended to be
higher for the individualised dyspnoea questions
compared to the standardised dyspnoea questions
(P ¼ 0:07 for the CRQ-IA and P ¼ 0:10 for the CRQ-
SA).
We show the longitudinal validity represented by
the correlations between CRQ change scores and
change scores of the FT, SF-36, 6MWT and Borg
scale in Tables 4 and 5. Most of the correlation
coefficients for the change scores were higher in
the groups randomised to the CRQ-SA.
Time required completing the CRQ-IA and the
CRQ-SA with individualised dyspnoea questions was
for both administration formats 16min at baseline
and 10min at follow-up. Administration time for
CRQ-IA and the CRQ-SA with standardised dyspnoea
questions was for both formats 8min at baseline
and 8 (CRQ-IA) and 7 (CRQ-SA) at follow-up. Thus,
patients needed less time to complete the stan-
dardised CRQ-SA while the mode of administration
(self versus interviewer) did not affect the time
required for completion.
There were more unanswered items in the
standardised than in the individualised dyspnoea
domain. 90% of the respondents completed five, 5%
four and 5% three individual dyspnoea questions at
baseline. For the standardised questions, 66% of
patients completed five, 26% four and 8% three
dyspnoea questions. At follow-up, 66% of the
respondents completed five, 11% four and 18%
three individual dyspnoea questions. 50% of the
patients completed five, 18% four and 26% three
standardised dyspnoea questions at follow-up.
Patients frequently responded ‘‘not applicable’’ to
those questions that included activities, which
patients did not perform during the rehabilitation
program. All patients completed all items of the
fatigue, emotion and mastery domain at baseline.
At follow up, 100% of the patients completed all
items of the mastery domain, 97% all items of the
fatigue domain and 92% (CRQ-IA) or 97% (CRQ-SA),
respectively, all items of the emotion domain.
Discussion
We validated four formats of the German CRQ
concurrently in a randomised trial. All four formats
were highly responsive to HRQL changes resulting
from respiratory rehabilitation. Longitudinal valid-
ity was better for the CRQ-SA.
In general, baseline scores were lower for the
CRQ-SA (Table 2). Although lower baseline scores
could result in larger improvements, we did
observe higher responsiveness only for the fatigue
domain of the CRQ-SA compared to the CRQ-IA
(Table 3). We found differences between the
individualised and standardised dyspnoea domains
for both the CRQ-IA and CRQ-SA that failed to reach
conventional levels of statistical significance. A
likely explanation for increased responsiveness is
that the individualised dyspnoea questions focus on
important activities and patients may perceive
larger benefits from effective interventions such
as respiratory rehabilitation compared to standar-
dised questions. Another explanation could be that
baseline scores of the individualised questions were
lower for both the CRQ-IA and CRQ-SA because
patients chose activities causing the most severe
dyspnoea.
The difference in responsiveness between the
standardised and the individualised dyspnoea
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Table 3 Change scores of the interviewer and self-administered format of the CRQ.
Domain CRQ-IA (n ¼ 38) P valuen CRQ-SA (n ¼ 33) P valuen P valuew
Individualised dyspnoea 1.02 (0.76–1.28) o0.001 1.25 (0.86–1.64) o0.001 0.32
Standardised dyspnoea 0.79 (0.52–1.06) o0.001 1.04 (0.63–1.46) o0.001 0.28
Fatigue 0.83 (0.55–1.12) o0.001 1.39 (1.03–1.75) o0.001 0.02
Emotional function 1.03 (0.78–1.28) o0.001 1.12 (0.73–1.51) o0.001 0.73
Mastery 0.88 (0.61–1.16) o0.001 1.22 (0.77–1.66) o0.001 0.21
CRQ domain scores with values from 1 (largest impairment) to 7 (no impairment); CRQ-IA¼ interviewer administered German
chronic respiratory questionnaire; CRQ-SA¼ self-administered German chronic respiratory questionnaire; Values are mean (95%
confidence interval).
nP-values for paired t-tests to compare baseline and follow up scores of the CRQ-IA and CRQ-SA.
wP-values for independent t-tests to compare the change scores of the CRQ-IA and CRQ-SA.
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domain may have important consequences for
clinical trials because it affects sample size. Given
the same power and level of statistical significance
to detect an identical change in HRQL the required
sample size in a trial using the standardised
dyspnoea domain increases two-fold compared to
using the individualised domain. The effect of
decreased responsiveness with the standardised
dyspnoea domain may be relevant for studies with
sample size limitations. In these studies, investiga-
tors could use the individualised CRQ dyspnoea
domain. It is important to note that changing to
standardised items will not reduce the correlation
between change in the CRQ dyspnoea domain and
change in other HRQL measures. In fact, the
correlations between change scores were generally
higher in the group randomised to the CRQ-SA.
Therefore, if large sample sizes are feasible and
investigators feel the greater ease of the standar-
dised items is important in their study, they can
choose the standardised approach without fearing
they are compromising the CRQs validity as a
measure of change over time or cross-sectionally
(manuscript in preparation).
For both the interviewer and self-administered
CRQ, there were few missing items for the fatigue,
emotional function and mastery domain. However,
we observed more missing items for the standar-
dised than for the individualised dyspnoea ques-
tions. The latter finding is not surprising because on
the individualised domain patients can choose
important activities themselves. Therefore, pa-
tients are more likely to perform these activities
compared with activities provided in the standar-
dised dyspnoea domain. Nevertheless, 94% of all
patients completed at least three items at baseline
and follow up for both the individualised and
standardised domain. If less than three items would
have been completed by a large number of
patients, validity would have suffered whereas
responsiveness is not much affected if there are
at least two completed items per domain.28
The strengths of our trial include the rigorous
methodological approach and the validation of the
questionnaire using an intervention of known
effectiveness.7 We trained all interviewers alike
to ensure equal adherence to the study protocol.
We conducted a multicentre trial in three countries
to validate a single CRQ that is applicable in the
German-speaking countries in Europe. Finally, we
used random allocation, which allowed us to
validate four different formats of the CRQ concur-
rently and to make direct comparisons between
them.
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Table 4 Longitudinal validity for the individualised and standardised dyspnoea domains. Correlations for change
scoresn.
Instrument and domain CRQ-IA dyspnoea domains CRQ-SA dyspnoea domains
Individualisedn Standardisedn Individualisedn Standardisedn
Feeling thermometer 0.38 0.21w 0.42 0.53w
(0.23;0.53) (0.05;0.37) (0.27;0.57) (0.39;0.67)
SF-36-General health
perception index
0.16 0.02w 0.41 0.46w
(0.00;0.32) (0.19;0.15) (0.26;0.56) (0.31;0.61)
SF-36-Physical
functioning index
0.20 0.04w 0.16 0.30w
(0.04;0.36) (0.21;0.13) (0.00;0.32) (0.14;0.46)
Mental health index 0.06 0.05w 0.25 0.40w
(0.11;0.23) (0.12;0.22) (0.09;0.41) (0.25;0.55)
SF-36-Vitality index 0.26z 0.09z 0.16 0.03
(0.42;0.10) (0.08;0.26) (0.32;0.00) (0.14;0.20)
Six minutes walk test 0.39z 0.06z 0.01 0.02
(0.24;0.54) (0.11;0.23) (0.18;0.16) (0.19;0.15)
Borg scale 0.50 0.33 0.46 0.54
(0.64;0.36) (0.49;0.17) (0.61;0.31) (0.68;0.40)
CRQ-IA¼ Interviewer administered German chronic respiratory questionnaire; CRQ-SA¼ self-administered German chronic
respiratory questionnaire.
nPearson correlation coefficient (95% confidence intervals); r40:28 significant at Po0:05:
wIndicate significant differences between the domains of the CRQ-IA and CRQ-SA.
zIndicate significant differences between the individualised and standardised dyspnoea domains.
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Table 5 Longitudinal validityn for the fatigue, emotion and mastery domains.
Instrument and domain CRQ-IA Domains CRQ-SA Domains
Fatiguen Emotionn Masteryn Fatiguen Emotionn Masteryn
Feeling thermometer 0.22 0.27 0.33 0.47 0.42 0.55
(0.06;0.38) (0.11;0.43) (0.17;0.49) (0.32;0.62) (0.27;0.57) (0.41;0.69)
SF-36-General health perception index 0.34 0.42 0.29 0.56 0.44 0.39
(0.18;0.50) (0.27;0.57) (0.13;0.45) (0.42;0.70) (0.29;0.59) (0.24;0.54)
SF-36-Physical functioning index 0.18 0.02w 0.10 0.41 0.38w 0.38
(0.02;0.34) (0.15;0.19) 0.07;0.27) (0.26;0.56) (0.23;0.53) (0.23;0.53)
SF-36-Mental health index 0.23 0.41 0.33 0.40 0.47 0.39
(0.07;0.39) (0.26;0.56) (0.17;0.49) (0.25;0.55) (0.32;0.62) (0.24;0.54)
SF-36-Vitality index 0.37 0.30 0.31 0.49 0.41 0.38
(0.22;0.52) (0.14;0.46) (0.15;0.47) (0.34;0.64) (0.26;0.56) (0.23;0.53)
Six minutes walk test 0.15 0.10 0.07 0.18 0.09 0.05
(0.31;0.01) (0.27;0.07) (0.24;0.10) (0.34;0.02) (0.26;0.08) (0.22;0.12)
Borg scale 0.48 0.35 0.35w 0.57 0.64 0.68w
(0.63;0.33) (0.51;0.19) (0.51;0.19) (0.71;0.43) (0.77;0.51) (0.80;0.56)
Correlations for change scores.
CRQ-IA¼ interviewer administered German chronic respiratory questionnaire; CRQ-SA¼ self-administered German chronic respiratory questionnaire.
nPearson correlation coefficient (95% confidence intervals); r40:28 significant at Po0:05:
wIndicate significant differences between the domains of the CRQ-IA and CRQ-SA.
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The trial had the following weaknesses. Follow-
up evaluation was performed at the end of the
rehabilitation program rather than upon return to
the home environment. In addition, due to the
absence of a validated German disease specific
HRQL instrument and, therefore, we were limited
to the use of generic instruments for validation.
However, we demonstrated similar improvement of
HRQL compared to other respiratory rehabilitation
trials.24,29
In conclusion, we validated four responsive and
valid versions of the CRQ. The resource and time
consuming interviewer administration using indivi-
dualised dyspnoea questions are not any longer a
hindrance for the use of the CRQ. If one accepts the
presumably lower responsiveness of the standar-
dised dyspnoea questions, the CRQ-SA is an easily
applicable instrument.
Funding: GlaxoSmithKline Switzerland and the
Swiss Lung League funded this study with grants to
the Horten Centre. The sponsors were not involved
in the study design, conduction of the trial, analysis
of data and manuscript writing. MB joined Glaxo-
SmithKline Germany this year for six months. This
engagement was not in relation to this research
project.
Acknowledgements
The CRQ-IA and CRQ-SA are copyrighted by McMas-
ter University; Principal Authors Dr. Gordon Guyatt
and Dr. Holger Sch .unemann. Use of the instrument
requires licensing.
We would like to thank Cornelia Flamann
(Zuercher Hoehenklinik Wald), Dr. Martin Frey and
Dr. Thomas Grueter (both Klinik Barmelweid) for
data collection in their centres.
References
1. World Health Report. World Health Organization.
www.who.int/whr/2000/en/statistics.htm. Geneva: 2000.
2. WHO. The Tobacco Free Iniative, Geneva: The Tobacco
Atlas; 2002.
3. Forey BA, Lee PN, Fry JS. Updating UK estimates of age, sex
and period specific cumulative constant tar cigarette
consumption per adult. Thorax 1998;53:875–8.
4. Cigarette smoking among adultsFUnited States, 2000.
MMWR Morb Mortal Wkly Rep 2002; 51: 642–45.
5. Swiss Federal Statistical Office. Neuch#atel: Swiss Health
Survey; 1998.
6. Leuenberger P, Kunzli N, Ackermann-Liebrich U, et al.
Swiss Study on Air Pollution and Lung Diseases in Adults
(SAPALDIA). Schweiz Med Wochenschr 1998;128:150–61.
7. Lacasse Y, Brosseau L, Milne S, et al. Pulmonary rehabilita-
tion for chronic obstructive pulmonary disease. Cochrane
Database Syst Rev 2002;CD003793.
8. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related
quality of life. Ann Intern Med 1993;118:622–9.
9. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers
LW. A measure of quality of life for clinical trials in chronic
lung disease. Thorax 1987;42:773–8.
10. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-
complete measure of health status for chronic airflow
limitation. The St. George’s Respiratory Questionnaire. Am
Rev Respir Dis 1992;145:1321–7.
11. Wijkstra PJ, TenVergert EM, van Altena R, et al. Reliability
and validity of the chronic respiratory questionnaire (CRQ).
Thorax 1994;49:465–7.
12. Larson JL, Covey MK, Berry JK, Wirtz S, Kim MJ. Reliability
and validity of the chronic respiratory disease question-
naire. Am Rev Respir Dis 1993;147:A530.
13. Rutten-van Molken M, Roos B, Van Noord JA. An empirical
comparison of the St George’s respiratory questionnaire
(SGRQ) and the chronic respiratory disease questionnaire
(CRQ) in a clinical trial setting. Thorax 1999;54:
995–1003.
14. Singh SJ, Sodergren SC, Hyland ME, Williams J, Morgan MD. A
comparison of three disease-specific and two generic health-
status measures to evaluate the outcome of pulmonary
rehabilitation in COPD. Respir Med 2001;95:71–7.
15. Jaeschke R, Singer J, Guyatt GH. Measurement of health
status. Ascertaining the minimal clinically important differ-
ence. Control Clin Trials 1989;10:407–15.
16. Redelmeier DA, Guyatt GH, Goldstein RS. Assessing the
minimal important difference in symptoms: a comparison of
two techniques. J Clin Epidemiol 1996;49:1215–9.
17. Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence
supporting an SEM-based criterion for identifying meaningful
intra-individual changes in health-related quality of life.
J Clin Epidemiol 1999;52:861–73.
18. Jones PW. Issues concerning health-related quality of life in
COPD. Chest 1995;107:187S–93S.
19. Williams JE, Singh SJ, Sewell L, Guyatt GH, Morgan MD.
Development of a self-reported chronic respiratory ques-
tionnaire (CRQ-SR). Thorax 2001;56:954–9.
20. Schunemann HJ, Griffith L, Jaeschke R, et al. A comparison
of the original chronic respiratory questionnaire with a
standardized version. Chest 2003;124:1421–9.
21. Guyatt GH, Townsend M, Keller JL, Singer J. Should study
subjects see their previous responses: data from a rando-
mized control trial. J Clin Epidemiol 1989;42:913–20.
22. Bullinger M. Creating and evaluation cross-cultural instru-
ments. In: Spilker B, editor. quality of life and pharmacoe-
conomics in clinical trials. Philadelphia: Lippincott; 1996.
p. 659–68.
23. Bullinger M. German translation and psychometric testing of
the SF-36 Health Survey: preliminary results from the Iqola
project. International quality of life assessment. Soc Sci Med
1995;41:1359–66.
24. Griffiths TL, Burr ML, Campbell IA, et al. Results at 1 year of
outpatient multidisciplinary pulmonary rehabilitation: a
randomised controlled trial. Lancet 2000;355:362–8.
25. Schunemann HJ, Griffith L, Jaeschke R, Goldstein R,
Stubbing D, Guyatt GH. Evaluation of the Minimal
Important Difference for the Feeling Thermometer and the
St. George’s Respiratory Questionnaire in Patients with
Chronic Airflow Obstruction. J Clin Epidemiol 2003;56:
1170–6.
ARTICLE IN PRESS
Self-administration and standardisation of the chronic respiratory questionnaire 349
26. Kirsten DK, Taube C, Lehnigk B, Jorres RA, Magnussen H.
Exercise training improves recovery in patients with
COPD after an acute exacerbation. Respir Med 1998;92:
1191–8.
27. Guyatt G, Walter S, Norman G. Measuring change over time:
assessing the usefulness of evaluative instruments. J Chronic
Dis 1987;40:171–8.
28. Moran LA, Guyatt GH, Norman GR. Establishing the minimal
number of items for a responsive, valid, health-related
quality of life instrument. J Clin Epidemiol 2001;54:571–9.
29. Bendstrup KE, Ingemann JJ, Holm S, Bengtsson B. Out-
patient rehabilitation improves activities of daily living,
quality of life and exercise tolerance in chronic obstructive
pulmonary disease. Eur Respir J 1997;10:2801–6.
ARTICLE IN PRESS
350 M.A. Puhan et al.
